Recent Company News

• 02:54 AM ET Oct 20, 2025
  

  StreetAccount Summary - European pre-market trading update

• 02:05 AM ET Oct 20, 2025
  

  Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio (€1.20, 0.00)

• 05:10 PM ET Oct 07, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 11:37 AM ET Oct 06, 2025
  

  Pharming Group provides update on previously announced G&A expense reduction plan (€1.31, 0.00)

• 08:46 AM ET Oct 06, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 03:57 AM ET Oct 06, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (92 total)

• 06:08 PM ET Oct 03, 2025
  

  FDA grants orphan drug designation to leniolisib (Joenja) for common variable immunodeficiency (€1.38, 0.00)

• 04:08 AM ET Oct 03, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (90 total)

• 04:38 AM ET Oct 01, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:55 AM ET Oct 01, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (51 total)